All GeoVax Labs Articles
Dog Days of Summer Produces Sharp Reversal In Stocks This Week- ( $FIG $GLD $MCD $META $MODD $NVDA Rise!)
As July closed and the dog days of summer arrived, U.S. equities faced a sharp reversal, punctuating several weeks of bullish momentum with a sobering dose of volatility—a direct consequence of new trade tensions and discouraging labor market reports. Index Performance All four major U.S. i...
Aug 01, 2025
View Article
Wall Street Delivers Choppy Session While Figma IPO Surged To Close Out July – ( $EPRX $FIG $META $MODD $ORCL $SER $RIO Rise!)
Wall Street delivered a choppy session to close July, as early gains faded with investors digesting a flurry of corporate results, inflation commentary, and trade policy developments. Major indices ended modestly lower, reflecting profit-taking and caution ahead of key economic data due Friday. ...
Jul 31, 2025
View Article
U.S.-Based GeoVax Emerges as Key Monopoly Challenger Amid $2.99B Bavarian Nordic Takeover – ($GOVX $IBB $XBI)
Bavarian Nordic, a leading Danish vaccine manufacturer best known for its MVA-BN (Modified Vaccinia Ankara–Bavarian Nordic) smallpox and mpox vaccines, recently agreed to a $2.99 billion takeover by private equity firms Permira and Nordic Capital. Shareholders are being offered 233 Danish kroner ...
Jul 31, 2025
View Article
Cautious Investors Navigated Fed Fueled Volatile Session On Wednesday – ( $ADT $FTAI $GNRC $GOVX $HOOD $MCD $META $MODD $NVDA $ORCL $PLTR $WING Rise!)
Investors navigated a volatile session with major indices retreating from recent highs, as disappointment from earnings and cautious Federal Reserve guidance weighed on sentiment. Technology names fluctuated ahead of critical quarterly results, while macroeconomic headlines and fresh trade developm...
Jul 30, 2025
View Article
U.S. Stocks Reversed Course From Record Highs As Economic Data Painted A Nuanced Picture Tuesday – ( $GLD $GOVX $MCD $ORCL $RIO $SER Rise!)
Stocks pulled back as ma...
Jul 29, 2025
View Article
GeoVax Labs: Progress, Regulatory Wins, and Strong Analyst Outlook – ( $GOVX $IBB $XBI )
Q2 2025 Financial and Business Momentum GeoVax Labs (NASDAQ: GOVX) is set to deliver its second quarter 2025 results on Monday, July 28, promising insights into a period of robust growth and scientific achievement. Key EMA Regulatory Milestone A breakthrough for GeoVax in 2025 is the favor...
Jul 23, 2025
View Article
Nasdaq Dips, But Dow 30 & S&P 500 Power Forward On Tuesday – ( $ADT $GOVX $MCD $MODD $RIO $SER $SMMT $TSLA Rise!)
The major U.S. equity indices...
Jul 22, 2025
View Article
Record Stock Market Highs Continue On Monday – ( $GOVX $META $MODD $RIO $SMMT $TDOC Rise!)
Markets enter the heart of the earnings seas...
Jul 21, 2025
View Article
Wall Street Sets Record New Highs Amid Tech Surge, Tariff tensions, & Summer Earnings Momentum – ( $ASTS $GOVX $NVDA $PLTR $TSLA Rise!)
Equity markets have managed to shrug off trad...
Jul 18, 2025
View Article
Just Another Day Of Record Stock Market Highs Again On Thursday – ( $ADT $ASTS $EPRX $MCD $NVDA $ORCL $PLTR $RIO $SER $TDOC Rise!)
The U.S. equity markets marked another day o...
Jul 17, 2025
View Article
GeoVax Secures Patent for Groundbreaking Malaria Vaccine Platform – ( $GOVX $IBB $XBI )
In a move that both underlines scientific ingenuity and bolsters global health ambitions, GeoVax Labs, Inc. (GOVX) has announced the issuance of U.S. Patent No. 12,329,808, a milestone that covers a novel vaccine construct designed to prevent malaria infection. This patent, granted from applicat...
Jun 25, 2025
View Article
GeoVax Applauds FDA’s Green Light for Keytruda: A New Chapter in Head and Neck Cancer—and a Wink at Gedeptin’s Future – ( $GOVX $MRK $XBI )
In the ever-evolving world of oncology, every so often a regulatory decision comes along that feels less like a footnote and more like a new chapter. The U.S. Food and Drug Administration’s (FDA) recent approval of Merck’s (MRK) Keytruda® (pembrolizumab) for resectable, locally advanced hea...
Jun 24, 2025
View Article
GeoVax Labs: A Shot in the Arm for Global Health, with a European Twist – ( $GOVX $IBB $XBI )
In a world where vaccine innovation can sometimes feel like a slow-motion sprint, GeoVax Labs, Inc. (NASDAQ: GOVX) has just received a welcome boost—this time, courtesy of European regulators. The company, known for its nimble approach to tackling some of the world’s most persistent health threa...
Jun 18, 2025
View Article
Stay Informed. Stay Competitive.
Vista Partners offers an exclusive newsletter and content with daily, weekly, monthly and quarterly investing ideas, strategies, and marketing insights.
We value your privacy and will never share your information.
